← Every applicant

Zhejiang Jutai Pharm FDA Approvals

3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
BRIVARACETAMNew drugSep 8, 2026TABLET, ORAL
AMANTADINE HYDROCHLORIDENew drugSep 26, 2024TABLET, ORAL
METOPROLOL SUCCINATENew drugJul 26, 2024TABLET, EXTENDED RELEASE, ORAL

Related datasets